RYZB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: N/A

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

RayzeBio Insider Trading History Chart

RayzeBio Share Price & Price History

^$62.49

+0.30 (1.20%)

As of 02/26/2024 01:00 AM ET

RayzeBio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/19/2023	Global Investors Lp Viking	Major Shareholder	Buy	1,388,889	$18.00	$25,000,002.00	4,899,144
9/19/2023	Maha Katabi	Director	Buy	472,222	$18.00	$8,499,996.00	1,209,764

SEC Filings (Institutional Ownership Changes) for RayzeBio (NASDAQ:RYZB)

Institutional Buying and Selling by Quarter

RayzeBio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/5/2024	Wellington Management Group LLP	3,504,409	$215.91M	0.0%	-9.6%	5.848%
2/26/2024	Perceptive Advisors LLC	744,056	$46.26M	1.0%	-4.2%	1.242%
2/15/2024	Blackstone Inc.	108,090	$6.72M	0.0%	+8.1%	0.180%
2/14/2024	Hhlr Advisors LTD.	1,062,383	$66.05M	1.3%	-23.9%	1.773%
2/14/2024	Commodore Capital LP	383,638	$23.85M	2.1%	+32.8%	0.640%
2/14/2024	PenderFund Capital Management Ltd.	1,800	$0.11M	0.0%	N/A	0.003%
2/14/2024	Harvest Management LLC	50,000	$3.11M	2.9%	N/A	0.083%
2/14/2024	Water Island Capital LLC	225,565	$14.02M	1.4%	N/A	0.376%
2/13/2024	GABELLI & Co INVESTMENT ADVISERS INC.	38,850	$2.42M	0.5%	N/A	0.065%
2/13/2024	Gabelli Funds LLC	52,600	$3.27M	0.0%	N/A	0.088%
2/13/2024	Tower Research Capital LLC TRC	826	$51K	0.0%	+403.7%	0.001%
2/13/2024	Capital Research Global Investors	170,808	$10.62M	0.0%	-86.3%	0.285%
2/9/2024	Franklin Resources Inc.	511,401	$31.79M	0.0%	-38.6%	0.853%
2/7/2024	Versor Investments LP	80,771	$5.02M	1.0%	N/A	0.135%
2/7/2024	Alpine Associates Management Inc.	762,900	$47.43M	2.4%	N/A	1.273%
2/7/2024	Kellner Capital LLC	12,200	$0.76M	1.4%	N/A	0.020%
2/7/2024	Vivo Capital LLC	110,581	$6.88M	0.6%	-82.5%	0.185%
2/6/2024	Charles Schwab Investment Management Inc.	147,140	$9.15M	0.0%	N/A	0.246%
2/6/2024	BCK Capital Management LP	15,000	$0.93M	0.9%	N/A	0.025%
2/6/2024	M&T Bank Corp	7,480	$0.47M	0.0%	N/A	0.012%
2/6/2024	Amalgamated Bank	2,347	$0.15M	0.0%	N/A	0.004%
2/5/2024	Victory Capital Management Inc.	4,055	$0.25M	0.0%	N/A	0.007%
2/1/2024	Wolverine Asset Management LLC	11,700	$0.73M	0.0%	N/A	0.020%
2/1/2024	New York State Common Retirement Fund	8,969	$0.56M	0.0%	+796.9%	0.015%
1/30/2024	Strs Ohio	4,300	$0.27M	0.0%	N/A	0.007%
1/12/2024	SG Americas Securities LLC	8,138	$0.51M	0.0%	N/A	0.014%
12/13/2023	Teachers Retirement System of The State of Kentucky	19,131	$0.43M	0.0%	N/A	0.032%
12/6/2023	Citigroup Inc.	24,907	$0.55M	0.0%	N/A	0.042%
12/1/2023	Wellington Management Group LLP	3,876,186	$84.49M	0.0%	N/A	6.469%
11/15/2023	RTW Investments LP	46,300	$1.03M	0.0%	N/A	0.080%
11/15/2023	Redmile Group LLC	1,857,706	$41.24M	2.0%	N/A	3.192%
11/15/2023	Laurion Capital Management LP	971,913	$21.58M	0.1%	N/A	1.670%
11/15/2023	Acuta Capital Partners LLC	344,571	$7.65M	5.1%	N/A	0.592%
11/14/2023	venBio Partners LLC	5,158,162	$114.51M	32.5%	N/A	8.864%
11/14/2023	Braidwell LP	277,778	$6.17M	0.2%	N/A	0.477%
11/14/2023	Blackstone Inc.	100,000	$2.22M	0.0%	N/A	0.172%
11/14/2023	Soros Fund Management LLC	20,000	$0.44M	0.0%	N/A	0.034%
11/14/2023	Deerfield Management Company L.P. Series C	1,159,126	$25.73M	0.6%	N/A	1.992%
11/14/2023	Avidity Partners Management LP	500,000	$11.10M	0.4%	N/A	0.859%
11/14/2023	Monashee Investment Management LLC	27,500	$0.61M	0.3%	N/A	0.047%
11/13/2023	FMR LLC	1,138,972	$25.29M	0.0%	N/A	1.957%
11/13/2023	Maven Securities LTD	59,835	$1.33M	0.0%	N/A	0.103%
11/9/2023	Citigroup Inc.	24,907	$0.55M	0.0%	N/A	0.043%
11/8/2023	Vivo Capital LLC	633,576	$14.07M	1.7%	N/A	1.089%
11/3/2023	Versant Venture Management LLC	5,158,161	$114.51M	61.0%	N/A	8.864%
11/3/2023	Platinum Investment Management Ltd.	222,222	$4.93M	0.2%	N/A	0.382%
10/27/2023	TD Asset Management Inc	72,610	$1.61M	0.0%	N/A	0.125%

Data available starting January 2016

See Full Table

RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company's lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs). It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California. As of February 26, 2024, RayzeBio, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.

Today's Range

Now: $62.49

$62.49

50 Day Range

MA: $62.47

$62.27

$62.49

52 Week Range

Now: $62.49

$17.95

$62.51

Volume

N/A

Average Volume

553,592 shs

Market Capitalization

$3.74 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of RayzeBio?: RayzeBio's top insider shareholders include:
Global Investors Lp Viking (Major Shareholder)
Maha Katabi (Director)
Learn More about top insider investors at RayzeBio.